The company-led K quarantine changes the usage of corona vaccination without a deliberation procedure on the 27th, excluding the Central Pharmacist Deliberation Committee, which appears to be avoiding the obligation to publicize the Pharmaceutical Affairs Act.
The Korea Centers for Disease Control and Prevention said, "As the first vaccination was conducted on the 26th, the occurrence of the residual amount was confirmed on-site. In the event of the residual amount, the disease administration promptly decided and announced the policy for the treatment of the residual amount." I confirmed that there was no change.
On the 27th, the Vaccination Response Promotion Team sent an official letter to the vaccination site stating, "If the remaining amount remains after the recommended number of vaccinations, additional vaccinations are possible." Because it means reducing the amount of waste," he said to the media, saying, "The number of uses per bottle may vary depending on the type of syringe or nurse skill level," and reports of '7 Pfizer vaccinations are possible.'
Minister of SMEs and Startups Kwon Chil-seung said on the 18th at President Moon Jae-in and Poonglim Pharmatech's factory, "The Poonglim Vaccine Syringe is the crystallization of K-defense, created by the will and efforts of Korean small and medium-sized companies, Samsung's technology, and the support of the government."
President Moon said at Poonglim Pharmatech that day, “The general syringe can inoculate 5 people with one bottle of vaccine, whereas the minimum residual type syringe can inoculate 6 people by minimizing the amount of vaccine remaining in the syringe. By improving the efficiency of the syringe, 20% of the vaccine is saved, and in the end, the same effect as producing 20% more vaccines is achieved.” The help of Bioepis was great. I am grateful that Samsung Bioepis CEO Han-Seung Ko was present at this meeting," he said, "increased vaccine production by 20%."
The Pharmaceutical Affairs Act stipulated a mandatory announcement of'the usage, dosage, and other precautions necessary for use or handling.'
The government signed a vaccine contract with a pharmaceutical company such as Pfizer as a dose (one dose), and the increase in the number of vaccinations in a vial (bottle) of a dose is expected to result in additional cost demands.
On the 16th, the Agency for Disease Control and Prevention announced on the 16th that an additional contract was made for 23 million corona vaccines, including 3 million Pfizer vaccines and 20 million NovaVax vaccines. The contract was completed at the end of January. The syringe will be used for the AstraZeneca vaccination, which will be implemented next week."
In quarantine, imported vaccines were applied to a 20% increase in production by medical staff vaccinations, and in response to the opposition from medical staff, the Commissioner of Disease Control and Prevention Chung Eun-gyeong revealed at a regular briefing that “to minimize the amount of waste, the remaining amount is used within the range of utilization” and classified it as a “disposal vaccine”. .